---
figid: PMC6287026__fphar-09-01426-g001
figlink: /pmc/articles/PMC6287026/figure/F1/
number: F1
caption: Possible mechanisms of synergistic actions of the LABA/LAMA combination against
  inflammation. (A) Synergistic inhibitory effect of LABA/LAMA against ACh release
  from airway epithelial cells. Signaling via β2AR inhibits the function of OCT1,
  a transporter for the release of acetylcholine from airway epithelial cells, whereas
  signaling via M3 possibly upregulates the function of OCT1. Therefore, the LABA/LAMA
  combination synergistically inhibits the release of ACh. (B) Synergistic inhibitory
  effect of LABA/LAMA against the production of inflammatory mediators. Signaling
  via β2AR activates AC-cAMP-PKA signaling pathway. PKA inhibits ERK and p38MAPK pathways.
  In contrast, signaling via M3 activates PKC, which results in the activation of
  NF-κB. The combination of LABA and LAMA therefore possibly inhibits the production
  of pro-inflammatory mediators synergistically via inhibiting both MAPK and NF-κB
  pathways. ACh, acetylcholine; AC, adenylate cyclase; β2AR, beta-2 adrenergic receptor;
  cAMP, cyclic adenosine monophosphate; CHT1, high-affinity choline transporter 1;
  ERK, extracellular signal-regulated kinase; LABA, long-acting β2 agonist; LAMA,
  long-acting muscarinic antagonist; MAPK, mitogen-activated protein kinase; M3, acetylcholine
  muscarinic M3 receptor; NF-κB, nuclear factor-kappa B; OCT1, organic cationic transporter
  1; PKA, protein kinase A; PKC, protein kinase C.
pmcid: PMC6287026
papertitle: 'The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic
  Target for COPD.'
reftext: Mitsuhiro Yamada, et al. Front Pharmacol. 2018;9:1426.
pmc_ranked_result_index: '70727'
pathway_score: 0.9363368
filename: fphar-09-01426-g001.jpg
figtitle: Possible mechanisms of synergistic actions of the LABA/LAMA combination
  against inflammation
year: '2018'
organisms:
- Homo sapiens
ndex: 20bdd17b-df06-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6287026__fphar-09-01426-g001.html
  '@type': Dataset
  description: Possible mechanisms of synergistic actions of the LABA/LAMA combination
    against inflammation. (A) Synergistic inhibitory effect of LABA/LAMA against ACh
    release from airway epithelial cells. Signaling via β2AR inhibits the function
    of OCT1, a transporter for the release of acetylcholine from airway epithelial
    cells, whereas signaling via M3 possibly upregulates the function of OCT1. Therefore,
    the LABA/LAMA combination synergistically inhibits the release of ACh. (B) Synergistic
    inhibitory effect of LABA/LAMA against the production of inflammatory mediators.
    Signaling via β2AR activates AC-cAMP-PKA signaling pathway. PKA inhibits ERK and
    p38MAPK pathways. In contrast, signaling via M3 activates PKC, which results in
    the activation of NF-κB. The combination of LABA and LAMA therefore possibly inhibits
    the production of pro-inflammatory mediators synergistically via inhibiting both
    MAPK and NF-κB pathways. ACh, acetylcholine; AC, adenylate cyclase; β2AR, beta-2
    adrenergic receptor; cAMP, cyclic adenosine monophosphate; CHT1, high-affinity
    choline transporter 1; ERK, extracellular signal-regulated kinase; LABA, long-acting
    β2 agonist; LAMA, long-acting muscarinic antagonist; MAPK, mitogen-activated protein
    kinase; M3, acetylcholine muscarinic M3 receptor; NF-κB, nuclear factor-kappa
    B; OCT1, organic cationic transporter 1; PKA, protein kinase A; PKC, protein kinase
    C.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR3
  - SLC5A7
  - PRKAR2B
  - PRKD3
  - ADCY2
  - ADCY3
  - MAPK1
  - ADCY1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - ADCY4
  - ADCY10
  - LAMA1
  - PRKCA
  - PRKCB
  - MAPK3
  - PRKACG
  - NFKB1
  - ADCY5
  - PRKACB
  - PRKCD
  - ADCY7
  - ADCY8
  - ADCY9
  - PRKCZ
  - PRKCE
  - PRKCG
  - PRKACA
  - PRKCQ
  - ADCY6
  - PRKCI
  - PRKCH
  - Acetyl-CoA
  - Choline
genes:
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: CHT1
  symbol: CHT1
  source: hgnc_alias_symbol
  hgnc_symbol: SLC5A7
  entrez: '60482'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: LABA/LAMA
  symbol: LAMA
  source: hgnc_prev_symbol
  hgnc_symbol: LAMA1
  entrez: '284217'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
chemicals:
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Choline
  source: MESH
  identifier: D002794
diseases: []
figid_alias: PMC6287026__F1
redirect_from: /figures/PMC6287026__F1
figtype: Figure
---
